SELL and acute myeloid leukemia: The results were confirmed by a wilcoxon test of the expression of the two groups, which showed that the differences in the expression of IL7R, CCR7, KLRB1, SELL, and PTPRC were statistically significant between the AML group and the normal group (Fig. 4G).